Picture of Humanigen logo

HGENQ — Humanigen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Humanigen Inc Says Lenzilumab Treatment May Provide Enhanced Likelihood Of Survival Without Ventilation In Hospitalized Black And African-American Covid-19 Patients

Aug 4 (Reuters) - Humanigen Inc  HGEN.O :
    * LENZILUMAB TREATMENT MAY PROVIDE ENHANCED LIKELIHOOD OF
SURVIVAL
WITHOUT VENTILATION IN HOSPITALIZED BLACK AND AFRICAN-AMERICAN
COVID-19 PATIENTS
    * HUMANIGEN INC - LIVE-AIR PHASE 3 STUDY MET ITS PRIMARY
ENDPOINT
OF SURVIVAL WITHOUT VENTILATION

Source text for Eikon:  ID:nBw3sMS3da 
Further company coverage:  HGEN.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Humanigen

See all news